Liraglutide's safety, tolerability, pharmacokinetics, and pharmacodynamics in pediatric type 2 diabetes: a randomized, double-blind, placebo-controlled trial. [electronic resource]
Producer: 20150715Description: 679-87 p. digitalISSN:- 1557-8593
- Adolescent
- Age of Onset
- Belgium -- epidemiology
- Blood Glucose -- drug effects
- Body Weight -- drug effects
- Child
- Diabetes Mellitus, Type 2 -- blood
- Dose-Response Relationship, Drug
- Double-Blind Method
- Glucagon-Like Peptide 1 -- administration & dosage
- Glycated Hemoglobin -- drug effects
- Humans
- Hypoglycemic Agents -- administration & dosage
- Liraglutide
- Pediatric Obesity -- complications
- Prevalence
- Slovenia -- epidemiology
- Treatment Outcome
- United Kingdom -- epidemiology
- United States -- epidemiology
- Weight Loss -- drug effects
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.